Literature DB >> 8954854

Chronic Relapsing Experimental Allergic Encephalomyelitis in the SJL Mouse: Relevant Techniques

.   

Abstract

Experimental allergic encephalomyelitis (EAE) is a useful animal model for the study of autoantigen-specific T-lymphocyte responses in autoimmune demyelinating diseases of the central nervous system. EAE models, however, are quite variable clinically, pathologically, and immunologically depending upon both host factors and the method of disease induction. Since EAE in the SJL mouse presents as a chronic relapsing disease characterized by primary demyelination, it is an ideal model for the study of autoimmune mediated demyelination and immunoregulatory events leading to relapses in the human disease multiple sclerosis. This report reviews host factors that influence EAE, then focuses upon EAE in the SJL mouse in a detailed description of methodologies involved in passive and active EAE induction. The advantages of each induction method, passive and active, are discussed.

Entities:  

Year:  1996        PMID: 8954854     DOI: 10.1006/meth.1996.0121

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  3 in total

1.  Sex-dependent factors encoded in the immune compartment dictate relapsing or progressive phenotype in demyelinating disease.

Authors:  Tessa Dhaeze; Catherine Lachance; Laurence Tremblay; Camille Grasmuck; Lyne Bourbonnière; Sandra Larouche; Olivia Saint-Laurent; Marc-André Lécuyer; Rose-Marie Rébillard; Stephanie Zandee; Alexandre Prat
Journal:  JCI Insight       Date:  2019-03-21

Review 2.  The importance of studying sex differences in disease: The example of multiple sclerosis.

Authors:  Lisa C Golden; Rhonda Voskuhl
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

3.  Phytosterols ameliorate clinical manifestations and inflammation in experimental autoimmune encephalomyelitis.

Authors:  Michael Valerio; Hong-Biao Liu; Reid Heffner; Robert Zivadinov; Murali Ramanathan; Bianca Weinstock-Guttman; Atif B Awad
Journal:  Inflamm Res       Date:  2010-12-07       Impact factor: 4.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.